Home LiteratureArticle Details
PMID: 6945879 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cells.

Blood ·Vol. 58 ·No. 5 ·1981-11-00 ·Pages 1047-9

Levine MN, Fay JW, Jones NH, Metzgar RS, Haynes BF

Abstract

Cell surface antigens of the human bone marrow CFU-C have been studied. Human marrow cells were incubated with a variety of monoclonal antisera and complement prior to culture in semisolid media. By using indirect immunofluorescent studies, the percentage of bone marrow cells binding the antibodies was determined. The CFU-C phenotype is HLA+, la+, 4F2+, 3A1-, and DUALL-1-. This study provides information that is useful in the study of myeloid cell ontogeny and necessary for the use of some of these reagents in the treatment of bone marrow cells prior to human bone marrow transplantation in various clinical settings.

MeSH Terms
Animals Binding Sites, Antibody Bone Marrow Cells Colony-Forming Units Assay Complement System Proteins Cytotoxicity, Immunologic Granulocytes/cytology HLA Antigens Histocompatibility Antigens Class II Humans Immune Sera/pharmacology Macrophages/cytology Phenotype Rabbits
Chemicals
HLA Antigens Histocompatibility Antigens Class II Immune Sera Complement System Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Levine M N
Fay J W
Jones N H
Metzgar R S
Haynes B F
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
1981-11-00
Pages
1047-9
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NCI NIH HHS · CA 08975 · United States
NCI NIH HHS · CA 26401 · United States
NCI NIH HHS · CA 28936 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]